Market Intelligence chevron_right Medical Care chevron_right Organ Transplantation Immunosuppressive Drug
Global Report 2022

Global Organ Transplantation Immunosuppressive Drug Market Insights and Forecast to 2031

calendar_todayPublished: Feb 2022 descriptionPages: 109 categoryCategory: Medical Care
cloud_downloadRequest Sample Report
mailPre-Order Enquiry
local_offerGet Discount 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Organ Transplantation Immunosuppressive Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Calcineurin Inhibitors
        1.2.3 Antiproliferative Agents
        1.2.4 mTOR Inhibitors
        1.2.5 Antibodies
        1.2.6 Steroids
    1.3 Market by Application
        1.3.1 Global Organ Transplantation Immunosuppressive Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Kidney Transplant
        1.3.3 Bone Marrow Transplant
        1.3.4 Liver Transplant
        1.3.5 Heart Transplant
        1.3.6 Lungs Transplant
        1.3.7 Others Transplant
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Organ Transplantation Immunosuppressive Drug Market Perspective (2017-2028)
    2.2 Organ Transplantation Immunosuppressive Drug Growth Trends by Region
        2.2.1 Organ Transplantation Immunosuppressive Drug Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Organ Transplantation Immunosuppressive Drug Historic Market Size by Region (2017-2022)
        2.2.3 Organ Transplantation Immunosuppressive Drug Forecasted Market Size by Region (2023-2028)
    2.3 Organ Transplantation Immunosuppressive Drug Market Dynamics
        2.3.1 Organ Transplantation Immunosuppressive Drug Industry Trends
        2.3.2 Organ Transplantation Immunosuppressive Drug Market Drivers
        2.3.3 Organ Transplantation Immunosuppressive Drug Market Challenges
        2.3.4 Organ Transplantation Immunosuppressive Drug Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Organ Transplantation Immunosuppressive Drug Players by Revenue
        3.1.1 Global Top Organ Transplantation Immunosuppressive Drug Players by Revenue (2017-2022)
        3.1.2 Global Organ Transplantation Immunosuppressive Drug Revenue Market Share by Players (2017-2022)
    3.2 Global Organ Transplantation Immunosuppressive Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Organ Transplantation Immunosuppressive Drug Revenue
    3.4 Global Organ Transplantation Immunosuppressive Drug Market Concentration Ratio
        3.4.1 Global Organ Transplantation Immunosuppressive Drug Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Organ Transplantation Immunosuppressive Drug Revenue in 2021
    3.5 Organ Transplantation Immunosuppressive Drug Key Players Head office and Area Served
    3.6 Key Players Organ Transplantation Immunosuppressive Drug Product Solution and Service
    3.7 Date of Enter into Organ Transplantation Immunosuppressive Drug Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Organ Transplantation Immunosuppressive Drug Breakdown Data by Type
    4.1 Global Organ Transplantation Immunosuppressive Drug Historic Market Size by Type (2017-2022)
    4.2 Global Organ Transplantation Immunosuppressive Drug Forecasted Market Size by Type (2023-2028)
5 Organ Transplantation Immunosuppressive Drug Breakdown Data by Application
    5.1 Global Organ Transplantation Immunosuppressive Drug Historic Market Size by Application (2017-2022)
    5.2 Global Organ Transplantation Immunosuppressive Drug Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Organ Transplantation Immunosuppressive Drug Market Size (2017-2028)
    6.2 North America Organ Transplantation Immunosuppressive Drug Market Size by Type
        6.2.1 North America Organ Transplantation Immunosuppressive Drug Market Size by Type (2017-2022)
        6.2.2 North America Organ Transplantation Immunosuppressive Drug Market Size by Type (2023-2028)
        6.2.3 North America Organ Transplantation Immunosuppressive Drug Market Share by Type (2017-2028)
    6.3 North America Organ Transplantation Immunosuppressive Drug Market Size by Application
        6.3.1 North America Organ Transplantation Immunosuppressive Drug Market Size by Application (2017-2022)
        6.3.2 North America Organ Transplantation Immunosuppressive Drug Market Size by Application (2023-2028)
        6.3.3 North America Organ Transplantation Immunosuppressive Drug Market Share by Application (2017-2028)
    6.4 North America Organ Transplantation Immunosuppressive Drug Market Size by Country
        6.4.1 North America Organ Transplantation Immunosuppressive Drug Market Size by Country (2017-2022)
        6.4.2 North America Organ Transplantation Immunosuppressive Drug Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Organ Transplantation Immunosuppressive Drug Market Size (2017-2028)
    7.2 Europe Organ Transplantation Immunosuppressive Drug Market Size by Type
        7.2.1 Europe Organ Transplantation Immunosuppressive Drug Market Size by Type (2017-2022)
        7.2.2 Europe Organ Transplantation Immunosuppressive Drug Market Size by Type (2023-2028)
        7.2.3 Europe Organ Transplantation Immunosuppressive Drug Market Share by Type (2017-2028)
    7.3 Europe Organ Transplantation Immunosuppressive Drug Market Size by Application
        7.3.1 Europe Organ Transplantation Immunosuppressive Drug Market Size by Application (2017-2022)
        7.3.2 Europe Organ Transplantation Immunosuppressive Drug Market Size by Application (2023-2028)
        7.3.3 Europe Organ Transplantation Immunosuppressive Drug Market Share by Application (2017-2028)
    7.4 Europe Organ Transplantation Immunosuppressive Drug Market Size by Country
        7.4.1 Europe Organ Transplantation Immunosuppressive Drug Market Size by Country (2017-2022)
        7.4.2 Europe Organ Transplantation Immunosuppressive Drug Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Organ Transplantation Immunosuppressive Drug Market Size (2017-2028)
    8.2 Asia-Pacific Organ Transplantation Immunosuppressive Drug Market Size by Type
        8.2.1 Asia-Pacific Organ Transplantation Immunosuppressive Drug Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Organ Transplantation Immunosuppressive Drug Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Organ Transplantation Immunosuppressive Drug Market Share by Type (2017-2028)
    8.3 Asia-Pacific Organ Transplantation Immunosuppressive Drug Market Size by Application
        8.3.1 Asia-Pacific Organ Transplantation Immunosuppressive Drug Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Organ Transplantation Immunosuppressive Drug Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Organ Transplantation Immunosuppressive Drug Market Share by Application (2017-2028)
    8.4 Asia-Pacific Organ Transplantation Immunosuppressive Drug Market Size by Region
        8.4.1 Asia-Pacific Organ Transplantation Immunosuppressive Drug Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Organ Transplantation Immunosuppressive Drug Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Organ Transplantation Immunosuppressive Drug Market Size (2017-2028)
    9.2 Latin America Organ Transplantation Immunosuppressive Drug Market Size by Type
        9.2.1 Latin America Organ Transplantation Immunosuppressive Drug Market Size by Type (2017-2022)
        9.2.2 Latin America Organ Transplantation Immunosuppressive Drug Market Size by Type (2023-2028)
        9.2.3 Latin America Organ Transplantation Immunosuppressive Drug Market Share by Type (2017-2028)
    9.3 Latin America Organ Transplantation Immunosuppressive Drug Market Size by Application
        9.3.1 Latin America Organ Transplantation Immunosuppressive Drug Market Size by Application (2017-2022)
        9.3.2 Latin America Organ Transplantation Immunosuppressive Drug Market Size by Application (2023-2028)
        9.3.3 Latin America Organ Transplantation Immunosuppressive Drug Market Share by Application (2017-2028)
    9.4 Latin America Organ Transplantation Immunosuppressive Drug Market Size by Country
        9.4.1 Latin America Organ Transplantation Immunosuppressive Drug Market Size by Country (2017-2022)
        9.4.2 Latin America Organ Transplantation Immunosuppressive Drug Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Organ Transplantation Immunosuppressive Drug Market Size (2017-2028)
    10.2 Middle East & Africa Organ Transplantation Immunosuppressive Drug Market Size by Type
        10.2.1 Middle East & Africa Organ Transplantation Immunosuppressive Drug Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Organ Transplantation Immunosuppressive Drug Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Organ Transplantation Immunosuppressive Drug Market Share by Type (2017-2028)
    10.3 Middle East & Africa Organ Transplantation Immunosuppressive Drug Market Size by Application
        10.3.1 Middle East & Africa Organ Transplantation Immunosuppressive Drug Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Organ Transplantation Immunosuppressive Drug Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Organ Transplantation Immunosuppressive Drug Market Share by Application (2017-2028)
    10.4 Middle East & Africa Organ Transplantation Immunosuppressive Drug Market Size by Country
        10.4.1 Middle East & Africa Organ Transplantation Immunosuppressive Drug Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Organ Transplantation Immunosuppressive Drug Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 AbbVie
        11.1.1 AbbVie Company Details
        11.1.2 AbbVie Business Overview
        11.1.3 AbbVie Organ Transplantation Immunosuppressive Drug Introduction
        11.1.4 AbbVie Revenue in Organ Transplantation Immunosuppressive Drug Business (2017-2022)
        11.1.5 AbbVie Recent Developments
    11.2 Allergan Plc
        11.2.1 Allergan Plc Company Details
        11.2.2 Allergan Plc Business Overview
        11.2.3 Allergan Plc Organ Transplantation Immunosuppressive Drug Introduction
        11.2.4 Allergan Plc Revenue in Organ Transplantation Immunosuppressive Drug Business (2017-2022)
        11.2.5 Allergan Plc Recent Developments
    11.3 Astellas Pharma
        11.3.1 Astellas Pharma Company Details
        11.3.2 Astellas Pharma Business Overview
        11.3.3 Astellas Pharma Organ Transplantation Immunosuppressive Drug Introduction
        11.3.4 Astellas Pharma Revenue in Organ Transplantation Immunosuppressive Drug Business (2017-2022)
        11.3.5 Astellas Pharma Recent Developments
    11.4 Bristol-Myers Squibb Company
        11.4.1 Bristol-Myers Squibb Company Company Details
        11.4.2 Bristol-Myers Squibb Company Business Overview
        11.4.3 Bristol-Myers Squibb Company Organ Transplantation Immunosuppressive Drug Introduction
        11.4.4 Bristol-Myers Squibb Company Revenue in Organ Transplantation Immunosuppressive Drug Business (2017-2022)
        11.4.5 Bristol-Myers Squibb Company Recent Developments
    11.5 Roche
        11.5.1 Roche Company Details
        11.5.2 Roche Business Overview
        11.5.3 Roche Organ Transplantation Immunosuppressive Drug Introduction
        11.5.4 Roche Revenue in Organ Transplantation Immunosuppressive Drug Business (2017-2022)
        11.5.5 Roche Recent Developments
    11.6 GlaxoSmithKline plc
        11.6.1 GlaxoSmithKline plc Company Details
        11.6.2 GlaxoSmithKline plc Business Overview
        11.6.3 GlaxoSmithKline plc Organ Transplantation Immunosuppressive Drug Introduction
        11.6.4 GlaxoSmithKline plc Revenue in Organ Transplantation Immunosuppressive Drug Business (2017-2022)
        11.6.5 GlaxoSmithKline plc Recent Developments
    11.7 Novartis AG
        11.7.1 Novartis AG Company Details
        11.7.2 Novartis AG Business Overview
        11.7.3 Novartis AG Organ Transplantation Immunosuppressive Drug Introduction
        11.7.4 Novartis AG Revenue in Organ Transplantation Immunosuppressive Drug Business (2017-2022)
        11.7.5 Novartis AG Recent Developments
    11.8 Pfizer
        11.8.1 Pfizer Company Details
        11.8.2 Pfizer Business Overview
        11.8.3 Pfizer Organ Transplantation Immunosuppressive Drug Introduction
        11.8.4 Pfizer Revenue in Organ Transplantation Immunosuppressive Drug Business (2017-2022)
        11.8.5 Pfizer Recent Developments
    11.9 Sanofi S.A.
        11.9.1 Sanofi S.A. Company Details
        11.9.2 Sanofi S.A. Business Overview
        11.9.3 Sanofi S.A. Organ Transplantation Immunosuppressive Drug Introduction
        11.9.4 Sanofi S.A. Revenue in Organ Transplantation Immunosuppressive Drug Business (2017-2022)
        11.9.5 Sanofi S.A. Recent Developments
    11.10 Veloxis Pharmaceuticals A/S
        11.10.1 Veloxis Pharmaceuticals A/S Company Details
        11.10.2 Veloxis Pharmaceuticals A/S Business Overview
        11.10.3 Veloxis Pharmaceuticals A/S Organ Transplantation Immunosuppressive Drug Introduction
        11.10.4 Veloxis Pharmaceuticals A/S Revenue in Organ Transplantation Immunosuppressive Drug Business (2017-2022)
        11.10.5 Veloxis Pharmaceuticals A/S Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables
    Table 1. Global Organ Transplantation Immunosuppressive Drug Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Calcineurin Inhibitors
    Table 3. Key Players of Antiproliferative Agents
    Table 4. Key Players of mTOR Inhibitors
    Table 5. Key Players of Antibodies
    Table 6. Key Players of Steroids
    Table 7. Global Organ Transplantation Immunosuppressive Drug Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 8. Global Organ Transplantation Immunosuppressive Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Organ Transplantation Immunosuppressive Drug Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Organ Transplantation Immunosuppressive Drug Market Share by Region (2017-2022)
    Table 11. Global Organ Transplantation Immunosuppressive Drug Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Organ Transplantation Immunosuppressive Drug Market Share by Region (2023-2028)
    Table 13. Organ Transplantation Immunosuppressive Drug Market Trends
    Table 14. Organ Transplantation Immunosuppressive Drug Market Drivers
    Table 15. Organ Transplantation Immunosuppressive Drug Market Challenges
    Table 16. Organ Transplantation Immunosuppressive Drug Market Restraints
    Table 17. Global Organ Transplantation Immunosuppressive Drug Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Organ Transplantation Immunosuppressive Drug Revenue Share by Players (2017-2022)
    Table 19. Global Top Organ Transplantation Immunosuppressive Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Organ Transplantation Immunosuppressive Drug as of 2021)
    Table 20. Ranking of Global Top Organ Transplantation Immunosuppressive Drug Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Organ Transplantation Immunosuppressive Drug Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Organ Transplantation Immunosuppressive Drug Product Solution and Service
    Table 24. Date of Enter into Organ Transplantation Immunosuppressive Drug Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Organ Transplantation Immunosuppressive Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Organ Transplantation Immunosuppressive Drug Revenue Market Share by Type (2017-2022)
    Table 28. Global Organ Transplantation Immunosuppressive Drug Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Organ Transplantation Immunosuppressive Drug Revenue Market Share by Type (2023-2028)
    Table 30. Global Organ Transplantation Immunosuppressive Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Organ Transplantation Immunosuppressive Drug Revenue Share by Application (2017-2022)
    Table 32. Global Organ Transplantation Immunosuppressive Drug Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Organ Transplantation Immunosuppressive Drug Revenue Share by Application (2023-2028)
    Table 34. North America Organ Transplantation Immunosuppressive Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 35. North America Organ Transplantation Immunosuppressive Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 36. North America Organ Transplantation Immunosuppressive Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 37. North America Organ Transplantation Immunosuppressive Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 38. North America Organ Transplantation Immunosuppressive Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 39. North America Organ Transplantation Immunosuppressive Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Europe Organ Transplantation Immunosuppressive Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 41. Europe Organ Transplantation Immunosuppressive Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 42. Europe Organ Transplantation Immunosuppressive Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 43. Europe Organ Transplantation Immunosuppressive Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 44. Europe Organ Transplantation Immunosuppressive Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 45. Europe Organ Transplantation Immunosuppressive Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Organ Transplantation Immunosuppressive Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Organ Transplantation Immunosuppressive Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Organ Transplantation Immunosuppressive Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Organ Transplantation Immunosuppressive Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 50. Asia Pacific Organ Transplantation Immunosuppressive Drug Market Size by Region (2017-2022) & (US$ Million)
    Table 51. Asia Pacific Organ Transplantation Immunosuppressive Drug Market Size by Region (2023-2028) & (US$ Million)
    Table 52. Latin America Organ Transplantation Immunosuppressive Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 53. Latin America Organ Transplantation Immunosuppressive Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 54. Latin America Organ Transplantation Immunosuppressive Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 55. Latin America Organ Transplantation Immunosuppressive Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 56. Latin America Organ Transplantation Immunosuppressive Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 57. Latin America Organ Transplantation Immunosuppressive Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Organ Transplantation Immunosuppressive Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Organ Transplantation Immunosuppressive Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Organ Transplantation Immunosuppressive Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Organ Transplantation Immunosuppressive Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 62. Middle East and Africa Organ Transplantation Immunosuppressive Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 63. Middle East and Africa Organ Transplantation Immunosuppressive Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 64. AbbVie Company Details
    Table 65. AbbVie Business Overview
    Table 66. AbbVie Organ Transplantation Immunosuppressive Drug Product
    Table 67. AbbVie Revenue in Organ Transplantation Immunosuppressive Drug Business (2017-2022) & (US$ Million)
    Table 68. AbbVie Recent Developments
    Table 69. Allergan Plc Company Details
    Table 70. Allergan Plc Business Overview
    Table 71. Allergan Plc Organ Transplantation Immunosuppressive Drug Product
    Table 72. Allergan Plc Revenue in Organ Transplantation Immunosuppressive Drug Business (2017-2022) & (US$ Million)
    Table 73. Allergan Plc Recent Developments
    Table 74. Astellas Pharma Company Details
    Table 75. Astellas Pharma Business Overview
    Table 76. Astellas Pharma Organ Transplantation Immunosuppressive Drug Product
    Table 77. Astellas Pharma Revenue in Organ Transplantation Immunosuppressive Drug Business (2017-2022) & (US$ Million)
    Table 78. Astellas Pharma Recent Developments
    Table 79. Bristol-Myers Squibb Company Company Details
    Table 80. Bristol-Myers Squibb Company Business Overview
    Table 81. Bristol-Myers Squibb Company Organ Transplantation Immunosuppressive Drug Product
    Table 82. Bristol-Myers Squibb Company Revenue in Organ Transplantation Immunosuppressive Drug Business (2017-2022) & (US$ Million)
    Table 83. Bristol-Myers Squibb Company Recent Developments
    Table 84. Roche Company Details
    Table 85. Roche Business Overview
    Table 86. Roche Organ Transplantation Immunosuppressive Drug Product
    Table 87. Roche Revenue in Organ Transplantation Immunosuppressive Drug Business (2017-2022) & (US$ Million)
    Table 88. Roche Recent Developments
    Table 89. GlaxoSmithKline plc Company Details
    Table 90. GlaxoSmithKline plc Business Overview
    Table 91. GlaxoSmithKline plc Organ Transplantation Immunosuppressive Drug Product
    Table 92. GlaxoSmithKline plc Revenue in Organ Transplantation Immunosuppressive Drug Business (2017-2022) & (US$ Million)
    Table 93. GlaxoSmithKline plc Recent Developments
    Table 94. Novartis AG Company Details
    Table 95. Novartis AG Business Overview
    Table 96. Novartis AG Organ Transplantation Immunosuppressive Drug Product
    Table 97. Novartis AG Revenue in Organ Transplantation Immunosuppressive Drug Business (2017-2022) & (US$ Million)
    Table 98. Novartis AG Recent Developments
    Table 99. Pfizer Company Details
    Table 100. Pfizer Business Overview
    Table 101. Pfizer Organ Transplantation Immunosuppressive Drug Product
    Table 102. Pfizer Revenue in Organ Transplantation Immunosuppressive Drug Business (2017-2022) & (US$ Million)
    Table 103. Pfizer Recent Developments
    Table 104. Sanofi S.A. Company Details
    Table 105. Sanofi S.A. Business Overview
    Table 106. Sanofi S.A. Organ Transplantation Immunosuppressive Drug Product
    Table 107. Sanofi S.A. Revenue in Organ Transplantation Immunosuppressive Drug Business (2017-2022) & (US$ Million)
    Table 108. Sanofi S.A. Recent Developments
    Table 109. Veloxis Pharmaceuticals A/S Company Details
    Table 110. Veloxis Pharmaceuticals A/S Business Overview
    Table 111. Veloxis Pharmaceuticals A/S Organ Transplantation Immunosuppressive Drug Product
    Table 112. Veloxis Pharmaceuticals A/S Revenue in Organ Transplantation Immunosuppressive Drug Business (2017-2022) & (US$ Million)
    Table 113. Veloxis Pharmaceuticals A/S Recent Developments
    Table 114. Research Programs/Design for This Report
    Table 115. Key Data Information from Secondary Sources
    Table 116. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Organ Transplantation Immunosuppressive Drug Market Share by Type: 2021 VS 2028
    Figure 2. Calcineurin Inhibitors Features
    Figure 3. Antiproliferative Agents Features
    Figure 4. mTOR Inhibitors Features
    Figure 5. Antibodies Features
    Figure 6. Steroids Features
    Figure 7. Global Organ Transplantation Immunosuppressive Drug Market Share by Application: 2021 VS 2028
    Figure 8. Kidney Transplant Case Studies
    Figure 9. Bone Marrow Transplant Case Studies
    Figure 10. Liver Transplant Case Studies
    Figure 11. Heart Transplant Case Studies
    Figure 12. Lungs Transplant Case Studies
    Figure 13. Others Transplant Case Studies
    Figure 14. Organ Transplantation Immunosuppressive Drug Report Years Considered
    Figure 15. Global Organ Transplantation Immunosuppressive Drug Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 16. Global Organ Transplantation Immunosuppressive Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 17. Global Organ Transplantation Immunosuppressive Drug Market Share by Region: 2021 VS 2028
    Figure 18. Global Organ Transplantation Immunosuppressive Drug Market Share by Players in 2021
    Figure 19. Global Top Organ Transplantation Immunosuppressive Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Organ Transplantation Immunosuppressive Drug as of 2021)
    Figure 20. The Top 10 and 5 Players Market Share by Organ Transplantation Immunosuppressive Drug Revenue in 2021
    Figure 21. North America Organ Transplantation Immunosuppressive Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. North America Organ Transplantation Immunosuppressive Drug Market Size Market Share by Type (2017-2028)
    Figure 23. North America Organ Transplantation Immunosuppressive Drug Market Size Market Share by Application (2017-2028)
    Figure 24. North America Organ Transplantation Immunosuppressive Drug Market Size Share by Country (2017-2028)
    Figure 25. United States Organ Transplantation Immunosuppressive Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Canada Organ Transplantation Immunosuppressive Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Europe Organ Transplantation Immunosuppressive Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 28. Europe Organ Transplantation Immunosuppressive Drug Market Size Market Share by Type (2017-2028)
    Figure 29. Europe Organ Transplantation Immunosuppressive Drug Market Size Market Share by Application (2017-2028)
    Figure 30. Europe Organ Transplantation Immunosuppressive Drug Market Size Share by Country (2017-2028)
    Figure 31. Germany Organ Transplantation Immunosuppressive Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. France Organ Transplantation Immunosuppressive Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. U.K. Organ Transplantation Immunosuppressive Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Italy Organ Transplantation Immunosuppressive Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Russia Organ Transplantation Immunosuppressive Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Nordic Countries Organ Transplantation Immunosuppressive Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Asia-Pacific Organ Transplantation Immunosuppressive Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 38. Asia Pacific Organ Transplantation Immunosuppressive Drug Market Size Market Share by Type (2017-2028)
    Figure 39. Asia Pacific Organ Transplantation Immunosuppressive Drug Market Size Market Share by Application (2017-2028)
    Figure 40. Asia Pacific Organ Transplantation Immunosuppressive Drug Market Size Share by Region (2017-2028)
    Figure 41. China Organ Transplantation Immunosuppressive Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Japan Organ Transplantation Immunosuppressive Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. South Korea Organ Transplantation Immunosuppressive Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Southeast Asia Organ Transplantation Immunosuppressive Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. India Organ Transplantation Immunosuppressive Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Australia Organ Transplantation Immunosuppressive Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Latin America Organ Transplantation Immunosuppressive Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Latin America Organ Transplantation Immunosuppressive Drug Market Size Market Share by Type (2017-2028)
    Figure 49. Latin America Organ Transplantation Immunosuppressive Drug Market Size Market Share by Application (2017-2028)
    Figure 50. Latin America Organ Transplantation Immunosuppressive Drug Market Size Share by Country (2017-2028)
    Figure 51. Mexico Organ Transplantation Immunosuppressive Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Brazil Organ Transplantation Immunosuppressive Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Middle East & Africa Organ Transplantation Immunosuppressive Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 54. Middle East and Africa Organ Transplantation Immunosuppressive Drug Market Size Market Share by Type (2017-2028)
    Figure 55. Middle East and Africa Organ Transplantation Immunosuppressive Drug Market Size Market Share by Application (2017-2028)
    Figure 56. Middle East and Africa Organ Transplantation Immunosuppressive Drug Market Size Share by Country (2017-2028)
    Figure 57. Turkey Organ Transplantation Immunosuppressive Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 58. Saudi Arabia Organ Transplantation Immunosuppressive Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 59. UAE Organ Transplantation Immunosuppressive Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 60. AbbVie Revenue Growth Rate in Organ Transplantation Immunosuppressive Drug Business (2017-2022)
    Figure 61. Allergan Plc Revenue Growth Rate in Organ Transplantation Immunosuppressive Drug Business (2017-2022)
    Figure 62. Astellas Pharma Revenue Growth Rate in Organ Transplantation Immunosuppressive Drug Business (2017-2022)
    Figure 63. Bristol-Myers Squibb Company Revenue Growth Rate in Organ Transplantation Immunosuppressive Drug Business (2017-2022)
    Figure 64. Roche Revenue Growth Rate in Organ Transplantation Immunosuppressive Drug Business (2017-2022)
    Figure 65. GlaxoSmithKline plc Revenue Growth Rate in Organ Transplantation Immunosuppressive Drug Business (2017-2022)
    Figure 66. Novartis AG Revenue Growth Rate in Organ Transplantation Immunosuppressive Drug Business (2017-2022)
    Figure 67. Pfizer Revenue Growth Rate in Organ Transplantation Immunosuppressive Drug Business (2017-2022)
    Figure 68. Sanofi S.A. Revenue Growth Rate in Organ Transplantation Immunosuppressive Drug Business (2017-2022)
    Figure 69. Veloxis Pharmaceuticals A/S Revenue Growth Rate in Organ Transplantation Immunosuppressive Drug Business (2017-2022)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AbbVie
Allergan Plc
Astellas Pharma
Bristol-Myers Squibb Company
Roche
GlaxoSmithKline plc
Novartis AG
Pfizer
Sanofi S.A.
Veloxis Pharmaceuticals A/S

Frequently Asked Questions

What is the USP of the report? expand_more
Organ Transplantation Immunosuppressive Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
What are the key content of the report? expand_more
Organ Transplantation Immunosuppressive Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
What are the value propositions and opportunities offered in this market research report? expand_more
Organ Transplantation Immunosuppressive Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.